Glucose-lowering agents, mainly insulin (19%) and metformin (75%), were prescribed to 16 individuals (11 patients with SW-CAH and 5 patients with SV-CAH), which was the second most common treatment in the studied population (only osteoporosis/osteopenia drugs were more frequently used). This evidence concerns the gene INS and congenital adrenal hyperplasia.